Amgen to reduce price of its cholesterol drug Repatha starting 2020 Medical Dialogues Bureau3 Nov 2019 9:15 AM ISTAmgen launched the lower-price option of Repatha last October, selling the drug to some patients under the list price of $5,850 per year because the...
Sanofi loses German patent case against Amgen over cholesterol drug Praluent Medical Dialogues Bureau9 Jun 2019 9:30 AM ISTIn the latest setback for Sanofi in the drawn-out patent dispute with Amgen, which is selling its rival drug Repatha, the German court ruled that...
Lupin gets USFDA nod for Atorvastatin Calcium tablets to lower cholesterol Farhat Nasim8 March 2019 9:45 AM ISTAtorvastatin Calcium tablets are indicated to lower cholesterol in blood for adults and children over 10 years of age, Lupin said. It works by...
Company to pay 35 million dollar for falsely marketing cholesterol drug Ruby Khatun Khatun25 Sept 2017 10:42 AM ISTBOSTON: A Massachusetts drug company has agreed to pay more than $35 million to resolve criminal and civil charges that it falsely marketed a...
